126 related articles for article (PubMed ID: 1410529)
1. Opioid peptides are substrates for the bifunctional enzyme LTA4 hydrolase/aminopeptidase.
Griffin KJ; Gierse J; Krivi G; Fitzpatrick FA
Prostaglandins; 1992 Sep; 44(3):251-7. PubMed ID: 1410529
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the aminopeptidase activity of epidermal leukotriene A4 hydrolase against the opioid dynorphin fragment 1-7.
Nissen JB; Iversen L; Kragballe K
Br J Dermatol; 1995 Nov; 133(5):742-9. PubMed ID: 8555027
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a catalytic role of tyrosine 383 in the peptidase reaction of leukotriene A4 hydrolase.
Blomster M; Wetterholm A; Mueller MJ; Haeggström JZ
Eur J Biochem; 1995 Aug; 231(3):528-34. PubMed ID: 7649151
[TBL] [Abstract][Full Text] [Related]
4. Albumins activate peptide hydrolysis by the bifunctional enzyme LTA4 hydrolase/aminopeptidase.
Orning L; Fitzpatrick FA
Biochemistry; 1992 May; 31(17):4218-23. PubMed ID: 1314659
[TBL] [Abstract][Full Text] [Related]
5. Leukotriene A4 hydrolase, insights into the molecular evolution by homology modeling and mutational analysis of enzyme from Saccharomyces cerevisiae.
Tholander F; Kull F; Ohlson E; Shafqat J; Thunnissen MM; Haeggström JZ
J Biol Chem; 2005 Sep; 280(39):33477-86. PubMed ID: 16024909
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of leukotriene A4 hydrolase/aminopeptidase by captopril.
Orning L; Krivi G; Bild G; Gierse J; Aykent S; Fitzpatrick FA
J Biol Chem; 1991 Sep; 266(25):16507-11. PubMed ID: 1885582
[TBL] [Abstract][Full Text] [Related]
7. The bifunctional enzyme leukotriene-A4 hydrolase is an arginine aminopeptidase of high efficiency and specificity.
Orning L; Gierse JK; Fitzpatrick FA
J Biol Chem; 1994 Apr; 269(15):11269-73. PubMed ID: 8157657
[TBL] [Abstract][Full Text] [Related]
8. Leukotriene A4 hydrolase: mapping of a henicosapeptide involved in mechanism-based inactivation.
Mueller MJ; Wetterholm A; Blomster M; Jörnvall H; Samuelsson B; Haeggström JZ
Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8383-7. PubMed ID: 7667299
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning and functional expression of a Caenorhabditis elegans aminopeptidase structurally related to mammalian leukotriene A4 hydrolases.
Baset HA; Ford-Hutchinson AW; O'Neill GP
J Biol Chem; 1998 Oct; 273(43):27978-87. PubMed ID: 9774412
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene A4 hydrolase. Inhibition by bestatin and intrinsic aminopeptidase activity establish its functional resemblance to metallohydrolase enzymes.
Orning L; Krivi G; Fitzpatrick FA
J Biol Chem; 1991 Jan; 266(3):1375-8. PubMed ID: 1846352
[TBL] [Abstract][Full Text] [Related]
11. Degradation of low-molecular-weight opioid peptides by vascular plasma membrane aminopeptidase M.
Bausback HH; Ward PE
Biochim Biophys Acta; 1986 Jul; 882(3):437-44. PubMed ID: 2873842
[TBL] [Abstract][Full Text] [Related]
12. Mechanism-based inactivation of leukotriene A4 hydrolase/aminopeptidase by leukotriene A4. Mass spectrometric and kinetic characterization.
Orning L; Gierse J; Duffin K; Bild G; Krivi G; Fitzpatrick FA
J Biol Chem; 1992 Nov; 267(32):22733-9. PubMed ID: 1331064
[TBL] [Abstract][Full Text] [Related]
13. Binding of Pro-Gly-Pro at the active site of leukotriene A4 hydrolase/aminopeptidase and development of an epoxide hydrolase selective inhibitor.
Stsiapanava A; Olsson U; Wan M; Kleinschmidt T; Rutishauser D; Zubarev RA; Samuelsson B; Rinaldo-Matthis A; Haeggström JZ
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4227-32. PubMed ID: 24591641
[TBL] [Abstract][Full Text] [Related]
14. Leukotriene A4 hydrolase: protection from mechanism-based inactivation by mutation of tyrosine-378.
Mueller MJ; Blomster M; Oppermann UC; Jörnvall H; Samuelsson B; Haeggström JZ
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5931-5. PubMed ID: 8650196
[TBL] [Abstract][Full Text] [Related]
15. Leukotriene A4 hydrolase, a bifunctional enzyme. Distinction of leukotriene A4 hydrolase and aminopeptidase activities by site-directed mutagenesis at Glu-297.
Minami M; Bito H; Ohishi N; Tsuge H; Miyano M; Mori M; Wada H; Mutoh H; Shimada S; Izumi T
FEBS Lett; 1992 Sep; 309(3):353-7. PubMed ID: 1516710
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of opioid peptides by cerebral microvascular aminopeptidase M.
Churchill L; Bausback HH; Gerritsen ME; Ward PE
Biochim Biophys Acta; 1987 Jan; 923(1):35-41. PubMed ID: 2879569
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene A4 hydrolase: abrogation of the peptidase activity by mutation of glutamic acid-296.
Wetterholm A; Medina JF; Rådmark O; Shapiro R; Haeggström JZ; Vallee BL; Samuelsson B
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9141-5. PubMed ID: 1357660
[TBL] [Abstract][Full Text] [Related]
18. Aminopeptidase B is structurally related to leukotriene-A4 hydrolase but is not a bifunctional enzyme with epoxide hydrolase activity.
Fukasawa KM; Fukasawa K; Harada M; Hirose J; Izumi T; Shimizu T
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):497-502. PubMed ID: 10215585
[TBL] [Abstract][Full Text] [Related]
19. Effects of metalloproteinase inhibitors on leukotriene A4 hydrolase in human airway epithelial cells.
Baker JR; Kylstra TA; Bigby TD
Biochem Pharmacol; 1995 Sep; 50(7):905-12. PubMed ID: 7575672
[TBL] [Abstract][Full Text] [Related]
20. Product formation controlled by substrate dynamics in leukotriene A4 hydrolase.
Stsiapanava A; Tholander F; Kumar RB; Qureshi AA; Niegowski D; Hasan M; Thunnissen M; Haeggström JZ; Rinaldo-Matthis A
Biochim Biophys Acta; 2014 Feb; 1844(2):439-46. PubMed ID: 24333438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]